Literature DB >> 15121105

Current therapeutic options for treating primary hyperhidrosis.

I K Nyamekye1.   

Abstract

Severe hyperhidrosis can cause extreme embarrassment that may lead to social and professional isolation. Therapeutic strategies to hyperhidrosis should employ the least invasive treatment that provides effective symptom control. The treatment options available for control of hyperhidrosis, non-surgical or surgical, differ in their invasiveness and efficacy. Mechanisms of action of antiperspirants, iontophoresis, cholinergic inhibitor drugs, botulinum toxin, and surgical sympathectomy are reviewed. There is little published evidence in the form of comparative randomised trials to support the use of one treatment over another. However, authors have tended to recommend those therapies that are available to their speciality. Specific therapies should be tailored to the patient's symptoms to gain maximum symptomatic improvement with minimum invasiveness and side-effects. To achieve this, the full range of treatment options should be available to, or accessible by the consulting doctor in order for the patient to have a meaningful choice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121105     DOI: 10.1016/j.ejvs.2004.01.023

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  5 in total

Review 1.  Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review.

Authors:  Hai-Wei Sang; Guo-Liang Li; Peng Xiong; Ming-Chuang Zhu; Min Zhu
Journal:  Surg Endosc       Date:  2017-04-07       Impact factor: 4.584

2.  A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.

Authors:  Hongya Xie; Tao Lu; Yimeng Zhu; Donglin Zhu; Tengteng Wei; Guangda Yuan; Yong Yang; Xiaoqiang Liu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-11       Impact factor: 1.195

3.  [Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis].

Authors:  M Streker; T Reuther; S Verst; M Kerscher
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

4.  Endoscopic thoracic sympathectomy for long QT syndrome.

Authors:  I Murphy; D Moneley; D Kelly; B Foley; S Sheehan
Journal:  Ir J Med Sci       Date:  2008-02-23       Impact factor: 1.568

Review 5.  Minimally Invasive Sympathicotomy for Palmar Hyperhidrosis and Facial Blushing: Current Status and the Hyperhidrosis Expert Center Approach.

Authors:  Michiel Kuijpers; Judith E van Zanden; Petra W Harms; Hubert E Mungroop; Massimo A Mariani; Theo J Klinkenberg; Wobbe Bouma
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.